drugset / Trial / NCT00480844

Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone

NCT00480844

Phase 4 Unknown 60 enrolled Sheba Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

In this study we intend to compare the effect of Sertindole to that of Risperidone on cognitive impairment in schizophrenia. Hypothesis: Sertindole will be as effective as Risperidone for treating cognitive impairment in schizophrenia and with fewer side effects.

Timeline

Start
2008-10
Primary completion
2011-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Risperidone Other / unclassified 4 mg Oral
Comparator Risperidone Other / unclassified 8 mg Oral
Subject Sertindole Small molecule 16 mg Oral
Subject Sertindole Small molecule 20 mg Oral
Subject Sertindole Small molecule 24 mg Oral

Indications